The AIT‘s Laboratory Cluster for Biomarker and Assay Development is a state-of-the-art research infrastructure dedicated to the discovery, validation and development of innovative diagnostic assays. Using the latest technologies, the laboratory enables the precise analysis of biological markers that are essential for personalised medicine, the early detection of diseases and biomedical research. 

The infrastructure includes several specialised laboratories: 

• Microarray laboratory: production and analysis of high-density protein and DNA arrays with high-resolution microarray spotters and scanners for complex genetic analyses 

• Sequencing laboratory: use of advanced sequencing technologies for targeted and genome-wide analyses 

• Assay development and validation laboratory: use of modern real-time PCR and multiplex analysis systems for highly sensitive and parallel test procedures 

• Cell culture laboratory: research into biological barriers and cell interactions with primary and tumor-generated cell models under controlled conditions 

The precise characterisation of biomarkers enables advances in medicine, pharmacology and biotechnological research. Through the combination of high-throughput analyses, cell models and bioinformatic data processing, the laboratory makes a significant contribution to the development of personalised diagnostic procedures and new therapeutic concepts. 

Thanks to a powerful IT infrastructure with high storage and computing capacities, large biomedical data sets can be efficiently analysed and made available for research. This supports the integration of AI-supported algorithms for the identification and validation of new biomarkers. 

With its modern infrastructure and interdisciplinary research, the AIT Biomarker Laboratory makes a significant contribution to medical innovation, improved diagnostics and patient-specific therapies.